WANBURYNSEWanbury Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 6 Feb, 2026 · 15:08 IST

Wanbury Q3 FY26 PAT up 13x; revenue up 22% Y-o

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

WANBURY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-7.1%Reaction day
₹262.10
prior close
₹246.92
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.8%-6.3% vs market
Pharmaceuticals peers, median of 159sector-0.6%-6.5% vs sector

On the reaction day the stock moved 6.3 pts less than Nifty Microcap 250 and 6.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
-0.8
15m
-0.4
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-7.1-0.8-6.3-0.6-6.5
Next day
-1.8+1.8-3.5+1.2-2.9
2d
+0.3+2.8-2.5+1.8-1.4
3d
+0.2+2.3-2.1+1.3-1.2
4d
+3.0+1.8+1.2+0.5+2.5
5d
-2.5+0.3-2.8+0.0-2.6
1w
-1.8+0.5-2.3-0.2-1.7
15d
+1.9-2.5+4.4-2.7+4.6
1m
-5.6-6.3+0.7-4.4-1.3
2m
-13.2-8.0-5.2-7.2-6.0
3m
-2.1+8.3-10.4+2.7-4.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Wanbury reported strong Q3 FY26 results. Revenue rose 21.7% Y-o-Y to Rs. 162.4 crore; 9M FY26 revenue grew 13.6% to Rs. 485.7 crore. EBITDA surged 81.7% to Rs. 26.9 crore with margin expanding to 16.5% from 11.0%. PAT jumped to Rs. 15.8 crore from Rs. 1.2 crore, while 9M PAT rose 332.5% to Rs. 44.4 crore. Growth was driven by higher API volumes, better capacity use, cost optimization, and lower finance costs.

Likely market impact

Sharp profit growth and margin expansion reflect strong operational turnaround, likely positive for stock sentiment.